Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

GT Biopharma (GTBP) Interest Coverage Ratio (2016 - 2021)

GT Biopharma (GTBP) has disclosed Interest Coverage Ratio for 12 consecutive years, with 826.27 as the latest value for Q4 2021.

  • On a quarterly basis, Interest Coverage Ratio fell 54047.5% to 826.27 in Q4 2021 year-over-year; TTM through Dec 2021 was 80.1, a 336.86% decrease, with the full-year FY2025 number at 97.81, changed N/A from a year prior.
  • Interest Coverage Ratio was 826.27 for Q4 2021 at GT Biopharma, down from 41.67 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 1.68 in Q1 2020 to a low of 826.27 in Q4 2021.
  • A 5-year average of 78.01 and a median of 3.6 in 2019 define the central range for Interest Coverage Ratio.
  • Peak YoY movement for Interest Coverage Ratio: soared 118.77% in 2020, then crashed 54047.5% in 2021.
  • GT Biopharma's Interest Coverage Ratio stood at 43.64 in 2017, then tumbled by 378.86% to 208.96 in 2018, then surged by 65.24% to 72.64 in 2019, then soared by 97.9% to 1.53 in 2020, then crashed by 54047.5% to 826.27 in 2021.
  • Per Business Quant, the three most recent readings for GTBP's Interest Coverage Ratio are 826.27 (Q4 2021), 41.67 (Q1 2021), and 1.53 (Q4 2020).